Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

334 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

NCT07230288

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328 Dothan, Alabama, United States
  • Christie Clinic on University /ID# 277871 Champaign, Illinois, United States
  • Hannibal Regional Hospital /ID# 277984 Hannibal, Missouri, United States
  • Centre d'Investigation Clinique Mauricie /ID# 277949 Trois-Rivières, Quebec, Canada
View all 57 locations
View Trial Details
Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT07036523

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Florida Gainesville, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 46 locations
View Trial Details
Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05571059

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Biosolutions Clinical Research La Mesa, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Miami VA Health System Miami, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View all 15 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

NCT07284459

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Instituto de Especialidades de la Salud Rosario - Clínica del Tórax Rosario, Santa Fe Province, Argentina
  • Centro de Investigaciones Médicas Tucumán - PPDS San Miguel de Tucumán, Tucumán Province, Argentina
  • IPR-Investigaciones en Patologías Respiratorias San Miguel de Tucumán, Tucumán Province, Argentina
  • Centro Modelo de Cardiología-Laprida 554 San Miguel de Tucumán, Tucumán Province, Argentina
View all 69 locations
View Trial Details
Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 373 locations
View Trial Details

Related conditions